Semaglutide: tested on its own

288 studies: no other medicine in its arm. Page 1 of 3. Open to participants first (106), then studies with results posted, then the rest; newest registration first within each.

• Semaglutide for Weight Management During Hormone Therapy for Early Breast CancerNot yet recruitingNCT07909889Phase 2Report a problem
• A Research Study Looking at Kidney and Heart Health in Adults With Type 2 Diabetes and Chronic Kidney Disease Treated With Semaglutide in ChinaRecruitingNCT07900438Phase 4Report a problem
• Lean Mass Changes With Semaglutide in Adults With Type 1 Diabetes and Overweight/Obesity.RecruitingNCT07891156Phase 2/3Report a problem
• Semaglutide for the Treatment of Cannabis Use DisorderNot yet recruitingNCT07879612Phase 2Report a problem
• Short Term Effects of Semaglutide on Body Composition and PerformanceNot yet recruitingNCT07874971Not applicableReport a problem
• Long-Term Effects of Semaglutide on Body Composition and Performance in RunningNot yet recruitingNCT07874932Not applicableReport a problem
• FutureShape FamilyRecruitingNCT07872904Phase 4Report a problem
• Immediate Versus Criterion-triggered Semaglutide for Suboptimal Clinical Response One Year After Primary Metabolic and Bariatric SurgeryNot yet recruitingNCT07859189Phase 4Report a problem
• Tapered Versus Abrupt Discontinuation of Semaglutide After Treatment of Recurrent Weight Gain or Suboptimal Response Following Metabolic and Bariatric SurgeryNot yet recruitingNCT07859176Phase 4Report a problem
• Semaglutide Given Before and After Conversion of Sleeve Gastrectomy to Roux-en-Y Gastric Bypass for Recurrent Weight GainNot yet recruitingNCT07859163Phase 4Report a problem
• Semaglutide 2.4 mg Once Weekly for Recurrent Weight Gain After Metabolic and Bariatric Surgery (RESURGE)Not yet recruitingNCT07859150Phase 4Report a problem
• Semaglutide Before Primary Metabolic and Bariatric Surgery in Patients With BMI 60 kg/m² or HigherNot yet recruitingNCT07859137Phase 4Report a problem
• Patient-centred Intervention With Virtual Support for Obesity and Kidney Transplant AccessNot yet recruitingNCT07858331Phase 4Report a problem
• SEMAFORCRANIO : Multicenter, Double-blind, Parallel, Randomized Controlled Trial of the Efficacy of Semaglutide in Hypothalamic Obesity Secondary to Craniopharyngioma in Children Aged 12 to 17 YearsNot yet recruitingNCT07845994Phase 3Report a problem
• Semaglutide, Weight Loss, and LNG-IUD for Conservative Treatment of Endometrial Atypical Hyperplasia and Grade 1 Endometrial CancerNot yet recruitingNCT07820358Phase 2Report a problem
• Postpartum Semaglutide to Reduce Cardiometabolic Risk After Gestational Diabetes MellitusNot yet recruitingNCT07797036Phase 2/3Report a problem
• OBESIAL: A Prospective Interventional Real-world Study of a Multidisciplinary Obesity Management ProgrammeRecruitingNCT07779343Not applicableReport a problem
• Semaglutide Dose Effects on Metabolic and Stress Hormone, Craving and Alcohol Use OutcomesRecruitingNCT07772960Phase 1Report a problem
• Research Study on How Well Oral Semaglutide Works for Weight Loss in Adults With Excess Body WeightRecruitingNCT07770841Phase 3Report a problem
• Semaglutide and Structured Lifestyle Support to Improve Heart and Blood Vessel Health in Postmenopausal Obese Breast Cancer Survivors Taking Aromatase InhibitorsNot yet recruitingNCT07769047Phase 4Report a problem
• Effects of Semaglutide on Brain Dopamine Responses to Food Cues in Adults With Obesity and Food Addiction TendenciesRecruitingNCT07732426Not applicableReport a problem
• Semaglutide for Low Back PainNot yet recruitingNCT07731256Phase 2Report a problem
• A Proof-of-Concept Study to Evaluate Topical-Lingual Semaglutide in Adults With ObesityRecruitingNCT07728383Phase 4Report a problem
• Preoperative Semaglutide Prior to Radical ProstatectomyNot yet recruitingNCT07727473Early Phase 1Report a problem
• Glucagon-Like Peptide-1 Receptor Agonists to Attenuate Metabolic Risk in Individuals With Duchenne Muscular DystrophyRecruitingNCT07642635Phase 1/2Report a problem
• GLP-1 RA Plus SOC Treatment in First-line, Metastatic Pancreatic, Colorectal, or Hepatocellular CancerRecruitingNCT07627191Early Phase 1Report a problem
• GLP-1 Agonists for Prevention of Recurrent Hypertriglyceridemic Acute PancreatitisNot yet recruitingNCT07617155Phase 4Report a problem
• Translational Health Research Into Vascular and Neurocognitive Effects of Weight LossRecruitingNCT07592546Phase 4Report a problem
• Personalized Pharmaco-Lifestyle Interventions for Severe Mental Illnesses (LIFETRAIN)Not yet recruitingNCT07586150Not applicableReport a problem
• Effect of Semaglutide on Cannabis Use in Adults With Cannabis Use DisorderRecruitingNCT07523633Phase 2Report a problem
• Glucagon-like Peptide-1 Receptor Agonists for Endovascular Stroke ThrombectomyNot yet recruitingNCT07511543Phase 2Report a problem
• Exercise and Diabetes Interventions to Improve Brain Health in Older Adults With Type 2 DiabetesNot yet recruitingNCT07485062Phase 4Report a problem
• A Clinical Study of Semaglutide Nasal Spray in Overweight or Obese AdultsRecruitingNCT07465965Phase 1Report a problem
• GLP-1 RA for Stage 1 Type 1 DiabetesNot yet recruitingNCT07430332Phase 2Report a problem
• Safety, Tolerability and Pharmacokinetics of a Subcutaneous Semaglutide ImplantNot yet recruitingNCT07430059Phase 1Report a problem
• Investigating the Impact of GLP-1 RA Therapy on Osteosarcopenia in Older Female Adults With DiabetesRecruitingNCT07428746Phase 3Report a problem
• Effects of Semaglutide on Clinical Outcomes and Metabolic Inflammation in PsoriasisRecruitingNCT07401992Phase 4Report a problem
• Pathogenesis of Chronic Kidney Disease Associated With Metabolic Dysfunction- Associated Fatty Liver Disease (MAFLD) and Treatment Response of Oral Semaglutide.RecruitingNCT07391267Not applicableReport a problem
• Semaglutide PrIor to CathEeter Ablation in Patients With Atrial FibrillationNot yet recruitingNCT07389941Phase 4Report a problem
• Triple Hypoglycemic Regimens In Patients With Newly Diagnosed Type 2 Diabetes MellitusRecruitingNCT07374328Phase 1/2Report a problem
• IMPACT-MACS: Adrenalectomy vs Semaglutide for Metabolic Outcomes in Mild Autonomous Cortisol SecretionRecruitingNCT07361874Not applicableReport a problem
• Semaglutide (Wegovy) Treatment for TrichotillomaniaNot yet recruitingNCT07282769Phase 2Report a problem
• Waiting on Atrial Fibrillation Intervention Therapy (WAIT) StudyRecruitingNCT07275697Phase 4Report a problem
• The Impact of Semaglutide Compared to Energy Restriction on Type 2 DiabetesRecruitingNCT07272343Phase 4Report a problem
• GLP-1 Receptor Agonists in Non-diabetic Patients With Psoriatic ArthritisNot yet recruitingNCT07251556Phase 4Report a problem
• Effect of Semaglutide on Embryo Quality in Overweight and Obese Patients Undergoing In Vitro Fertilization.RecruitingNCT07242534Phase 4Report a problem
• Repurposing Semaglutide for the Treatment of Cocaine Use DisorderRecruitingNCT07227948Phase 2Report a problem
• GLP-1 Receptor Agonists to Decrease Ethanol and CVD Risk in HIVRecruitingNCT07221214Phase 2Report a problem
• Cessation or Reduction of Alcohol Consumption in Veterans: A Randomized Controlled Trial for Alcohol Use Disorder (CRAVE)RecruitingNCT07218354Phase 3Report a problem
• Glutide for Ending MethamphetamineRecruitingNCT07204249Phase 2Report a problem
• Oral Semaglutide in Patients With Alzheimer's DiseaseNot yet recruitingNCT07200622Phase 2Report a problem
• Does Semaglutide Improve Depressive Symptoms in Patients With Major Depressive Disorder and Overweight or ObesityRecruitingNCT07136714Phase 4Report a problem
• Semaglutide in Patients Undergoing Transcatether Aortic Valve ReplacementNot yet recruitingNCT07090343Phase 3Report a problem
• The Role of Glucagon-Like Peptide-1 Receptor Agonists in Coronary Artery Diseases and Their Potential MechanismsNot yet recruitingNCT07073053Phase 4Report a problem
• Off-Label Medications for Alcohol Use Disorder Among Patients With HIV: Pilot Study 3 SemaglutideRecruitingNCT07040592Phase 2Report a problem
• Efficacy of Semaglutide in Improving Neurological Outcomes After Endovascular Thrombectomy for Acute Ischemic Stroke: A Randomized Double-Blind Controlled TrialNot yet recruitingNCT07030621Phase 3Report a problem
• Brain Plasticity and GLP-1 Receptor Agonist Treatment for ObesityNot yet recruitingNCT07021937Phase 3Report a problem
• Impact of Semaglutide on Tobacco Use and Related Health BehaviorsRecruitingNCT06986993Phase 4Report a problem
• Assessing Incretin Therapy for Cardiovascular Risk Reduction and Diabetes Remission( ITCRDR Study)Enrolling by invitationNCT06959784Phase 4Report a problem
• Effect of Semaglutide in Patients With Psoriasis and ObesityRecruitingNCT06937060Phase 3Report a problem
• Early Reinitiation of Semaglutide Post-Sleeve Gastrectomy in YouthRecruitingNCT06934655Phase 3Report a problem
• Semaglutide Treatment in Type 1 DiabetesNot yet recruitingNCT06909006Phase 3Report a problem
• JOULE - Metabolic Adaptation to Weight Loss in Response to a Behavioural Lifestyle Program With or Without Semaglutide in Adolescents With ObesityRecruitingNCT06852391Phase 4Report a problem
• Semaglutide's Weight Loss Effects in ObesityNot yet recruitingNCT06825793Not applicableReport a problem
• A Study Investigating Oral Semaglutide in People with Open-Angle GlaucomaRecruitingNCT06792422Phase 4Report a problem
• Glucagon-like Peptide 1 Receptor Agonist in Acute Large Vessel Occlusion Stroke After Endovascular TreatmentNot yet recruitingNCT06788626Phase 3Report a problem
• Characterization and Management of Metabolic Dysfunction-Associated Fatty Liver Disease (MAFLD)Not yet recruitingNCT06764056Not applicableReport a problem
• Glycemic and Weight Loss Effects of GLP-1R Agonist Therapy in Subjects With Spinal Cord Injury and Type 2 DiabetesRecruitingNCT06706284Phase 4Report a problem
• Semaglutide for Helping Opioid RecoveryRecruitingNCT06639464Phase 2Report a problem
• A Phase III Study Comparing the Weight Loss Effects of Semaglutide Injection and Wegovy®Not yet recruitingNCT06633783Phase 3Report a problem
• GLP-1R Agonist Treatment for Opioid Use DisorderRecruitingNCT06548490Phase 2Report a problem
• GLP-1 RA on Alcohol Consumption, Metabolism and Liver Parameters in Patients With Obesity and Fatty Liver DiseaseNot yet recruitingNCT06546384Not applicableReport a problem
• Mechanisms of Semaglutide Therapy in Heart Failure PatientsRecruitingNCT06541509Phase 1/2Report a problem
• Semaglutide for Metabolic Intervention and Adipose Loss to Treat Atrial FibrillationRecruitingNCT06499857Phase 3Report a problem
• Effect of GLP1 Receptor Agonist on Brain Insulin ResponsivenessRecruitingNCT06487832Not applicableReport a problem
• The Ameliorative Effects of GLP-1RA on Diabetic Cardiac Autonomatic NeuropathyRecruitingNCT06461377Phase 4Report a problem
• Semaglutide in Auto-HSCTNot yet recruitingNCT06449625Phase 2Report a problem
• Effect of Weight Loss on Physical and Cardiac Performance in People With Obesity and Heart FailureRecruitingNCT06423599Phase 2/3Report a problem
• Obesity Complicating Type 1 Diabetes: GLP-1 Analogue Anti-obesity TreatmentRecruitingNCT06411210Phase 2Report a problem
• Obesity Management for Kidney TRANSPLANTation: OK-TRANSPLANT 2RecruitingNCT06396416Phase 4Report a problem
• GLP-1Ra Impact on Metabolic Outcomes in Stage 2 T1DM While Receiving TeplizumabRecruitingNCT06338553Early Phase 1Report a problem
• The GAPSID Study - How GLP-1 Analogues Prevent Steroid-Induced DiabetesRecruitingNCT06318442Not applicableReport a problem
• The Effect of Semaglutide on Disordered Eating Behaviour in Type 2 Diabetic PatientsNot yet recruitingNCT06243536Phase 4Report a problem
• Subcutaneous Semaglutide in Systemic SclerodermaRecruitingNCT06149260Phase 1Report a problem
• Semaglutide GLP1 Agonists With Degludec Basal-bolus Insulin in Early Type 1 Diabetes to Basal-bolusNot yet recruitingNCT06057077Phase 1/2Report a problem
• GLUCOSE-MGH: Genetic Links Understood Through Challenge With Oral Semaglutide Exposure at MGHRecruitingNCT06003153Phase 4Report a problem
• Efficacy and Safety of Semaglutide Ingection in Subjects With Type 2 DiabetesNot yet recruitingNCT05950516Phase 3Report a problem
• Semaglutide and Vascular RegenerationRecruitingNCT05870462Phase 4Report a problem
• Trial of Semaglutide for Diabetic Kidney Disease in Type 1 DiabetesRecruitingNCT05822609Phase 2Report a problem
• Role of Semaglutide in Restoring Ovulation in Youth and Adults With Polycystic Ovary SyndromeRecruitingNCT05819853Phase 3Report a problem
• Type 1 Diabetes Impacts of Semaglutide on Cardiovascular OutcomesRecruitingNCT05819138Phase 3Report a problem
• Effects of Semaglutide on Intracranial Blood Flow and Brain-Barrier Permeability in Type-2 DiabetesRecruitingNCT05780905Phase 4Report a problem
• Feasibility of Semaglutide in Advanced Lung DiseaseRecruitingNCT05746039Phase 1/2Report a problem
• Semaglutide Treatment for Hyperglycaemia After Renal TransplantationRecruitingNCT05702931Phase 4Report a problem
• Semaglutide vs Metformin in Polycystic Ovary Syndrome (PCOS)Not yet recruitingNCT05646199Phase 2/3Report a problem
• Acute Subcutaneous SemaglutidE in Acute Ischemic sTrokeRecruitingNCT05630586Phase 2Report a problem
• Semaglutide for the Treatment of Glucose Intolerance in Women With Prior Gestational DiabetesRecruitingNCT05569772Phase 3Report a problem
• Randomized Double Blinded Placebo-Controlled w/Semaglutide to Prevent Weight Gain After Liver TransplantRecruitingNCT05424003Phase 2Report a problem
• Genetics of the Acute Response to Oral SemaglutideRecruitingNCT05340868Not applicableReport a problem
• Sit Less, Interact and Move More (SLIMM) 2 StudyRecruitingNCT05173714Phase 2Report a problem

← Semaglutide